Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | CAR T-cells and BiTEs for hematological malignancies

Dieter Hoelzer • 26 Mar 2019
EBMT 2019
General Antibodies CAR-T

Dieter Hoelzer, MD, PhD, of the University of Frankfurt, Frankfurt, Germany, discusses CAR T-cell therapy and Bi-specific T-cell engager (BiTEs) bispecific antibodies at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Dieter Hoelzer

15:02
The evolving landscape of ALL therapy and the impact of MRD
Dieter Hoelzer et al. • 17 May 2019
1:57
MRD negativity in ALL
Dieter Hoelzer • 26 Mar 2019
1:45
New aims and next steps for adult ALL induction therapy
Dieter Hoelzer • 22 Jun 2017
2:51
Two important therapies for ALL
Dieter Hoelzer • 22 Jun 2017

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals